Donglu Zhang
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Drug Transport and Resistance Mechanisms, Protein Degradation and Inhibitors
Most-Cited Works
- → Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans(2008)601 cited
- → GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP2C8: IMPLICATIONS FOR DRUG-DRUG INTERACTIONS(2005)327 cited
- → Preclinical experimental models of drug metabolism and disposition in drug discovery and development(2012)296 cited
- → Mass defect filter technique and its applications to drug metabolite identification by high‐resolution mass spectrometry(2009)289 cited
- → IN VITRO INHIBITION OF UDP GLUCURONOSYLTRANSFERASES BY ATAZANAVIR AND OTHER HIV PROTEASE INHIBITORS AND THE RELATIONSHIP OF THIS PROPERTY TO IN VIVO BILIRUBIN GLUCURONIDATION(2005)284 cited
- → Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis(2015)282 cited
- → In Vitro Assessment of Metabolic Drug-Drug Interaction Potential of Apixaban through Cytochrome P450 Phenotyping, Inhibition, and Induction Studies(2009)251 cited
- → Detection and Characterization of Metabolites in Biological Matrices Using Mass Defect Filtering of Liquid Chromatography/High Resolution Mass Spectrometry Data(2006)222 cited
- → Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor(2011)194 cited
- → Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity(2019)185 cited